Harvard Business Review

JANUARY 13, 2015

In pharmaceuticals, there are blockbuster drugs targeted at mass-markets segments. But insurers pay this price because Soliris is the only safe and effective treatment for these diseases and that price is less than the total cost of alternative treatments. But there is also Nordstrom, Louis Vuitton, and many high-end boutiques.

Market Segmentation 8

Market Segmentation Mass Marketing Price Pharmaceuticals 8

Harvard Business Review

APRIL 2, 2018

health care system, ranging from expensive imaging for benign medical conditions to routine pre-operative testing before low-risk surgeries like cataract surgery. Consider, for example, the debate around the pricing of new Hepatitis C Virus (HCV) therapies. HCV is a chronic infectious disease that affects 3 million or more Americans.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Strategy Driven

MARCH 18, 2011

PL and CM: Coherent companies – those that possess a capabilities system that aligns their strategy with their product/service portfolio – generate superior performance over time, which is what we call the coherence premium. SD : What is the ‘coherence premium?’. SD : What does it mean to have a ‘right to win?’.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

DECEMBER 18, 2014

It used to be that hospitals and health systems operated as islands, selecting and purchasing medical supplies, devices and medications in isolation, and keeping their operational and leadership practices to themselves. While collaboration is always challenging, the health care benefits are by now clear.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products. Demand is Shifting.

Globalization 9

Globalization Supply Chain Pharmaceuticals McKinsey 9

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces. It’s not just products.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

APRIL 22, 2015

This was the original purpose of forming corporations — to facilitate the production of products and services with the least amount of wasted time, materials, and labor. Many companies still compete this way and there continue to be successors to Taylorism, including business process reengineering and lean production.

Six Sigma 8

Six Sigma Company Lean Production Taylorism 8

Harvard Business Review

MAY 16, 2011

True collaboration always has open-ended elements — ranging from precisely how new innovations will be implemented, to how products will fare in the market, and even to what priorities partners will pursue in the face of changes in the environment. Recognizing this, Sun began to work more closely with Fujitsu and Texas Instruments.

Software 15

Software Licensing Long-term Telecommunications 15

Harvard Business Review

NOVEMBER 24, 2015

But those numbers are the equivalent of the price of the car, not the added value that the new ownership will produce after the merger. The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

APRIL 19, 2016

Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. For example, printing products on demand would significantly reduce the U.S. What happens, for example, if the value of a product’s underlying intellectual property overtakes its production value?

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

MARCH 2, 2011

McKinsey teams are beavering away in places like the United Arab Emirates and the 'Stans — Turkmenistan, say, or Tajikistan — but they're as likely to be doing operations projects as pure strategy work. The most intense competition between consulting firms is for "whale" engagements. Of course not," he replied.

Consultative 15

Consultative Strategy McKinsey Porter 15

Harvard Business Review

MAY 5, 2016

The country’s urbanized and large middle class has maintained a strong preference for foreign-made products despite restrictions due to U.S. There are some exemptions for humanitarian-designated sectors, such as agriculture, food products, health care, and civil aviation.). sanctions and a fragile economy. For non-U.S.-based

Tourism 8

Tourism Banking Due Diligence Hotels 8

Harvard Business Review

OCTOBER 26, 2015

If you were Walmart, no one else could afford the complicated technology required to track the demand logistics from shoppers in Peoria to production plants in China. Where only the largest organizations could operate 24-hour call centers, today, even small organizations have access to companies like Global Response.

Competitive Advantage 8

Competitive Advantage Pharmaceuticals Industry Trends 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. Are we going to have to work really hard to differentiate the product or products that result from the acquisition? billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

OCTOBER 26, 2011

In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail). Despite these gloomy headlines, three developments in the sector give us hope that the revolution in clean energy production is far from dead: 1.

Energy 11

Energy Finance IPO Biotechnology 11

Harvard Business Review

JANUARY 5, 2018

The chief marketing officers at consumer products companies, the heads of design at luxury apparel companies, and the heads of logistics at large retailers are cases in point. These are jobs in R&D, technology, and other areas vital to a firm’s strategic direction, product development, and process efficiency.

McKinsey 8

McKinsey Human Resources Reputation Brand 8

Harvard Business Review

FEBRUARY 20, 2014

Whereas we’ve been growing our manufacturing sector since the ’60s in terms of product volumes and dollar output, manufacturing employment hasn’t grown at all. Since then, America’s productivity lead has been growing sharply, not falling behind. Today, about 14 million Americans go to work making things, according to the BLS.

Intellectual Capital 8

Intellectual Capital Magazine Pharmaceuticals Creativity 8

Harvard Business Review

FEBRUARY 24, 2015

The first category is exogenous factors over which the business has little control: the growth of the markets into which it sells; the competitive intensity and thus the average profitability of the industry in which it operates; or the fragmentation of its industry and thus the scope for a growth-by-acquisition approach.

Chemicals 8

Chemicals How To Kahneman Reputation 8

Harvard Business Review

FEBRUARY 4, 2013

Levi Strauss, intriguingly, has used biomimetic techniques in developing new production techniques for jeans. Perhaps surprisingly, two leading examples come from pharmaceutical companies. We need true costing, true pricing, true taxing," says Ralph Thurm, Director of Deloitte Sustainability Strategies and Innovation.

EPS 8

EPS Innovation CEO Pharmaceuticals 8

Harvard Business Review

FEBRUARY 11, 2016

Google and Intel rely on experts in social science and biomechanics to develop transformative products by better understanding how people think about and use technology. Too often, purchasing departments manage the selection while operating managers—not involved in selection by fiat—are expected to make the relationship work.

Agility 8

Agility Organization Resources Fixed Costs 8

In the CEO Afterlife

JUNE 19, 2011

We operate by the mantra of “use it or you lose it.” As a young Brand Manager, I pounced on consumer insecurities, pumping products that solved bad breath, armpit odor, yellow teeth and bad skin. They know we can well afford their products. So do pharmaceutical giants Eli Lilly and Pfizer. Sure, we have our insecurities.

Advice 147

Advice Marketing Marketing Strategy Brand 147

Harvard Business Review

OCTOBER 24, 2014

Here are some of the challenges that I’ve observed: Product management. Successful IoT plays require more than simply adding connectivity to a product and charging for service — something many companies don’t immediately understand. Operations. Building an IoT offering requires design thinking from the get-go.

Productivity 8

Productivity Products Company Engineering 8

Harvard Business Review

NOVEMBER 28, 2017

One of your executives comes to you with a proposal: she wants to lower the quality of service at the restaurants, reduce product safety standards, use deceptive marketing practices, lower employee pay, and adopt worse environmental practices. Imagine you’re the CEO of a casual dining chain. But these effects were limited.

Company 8

Company Short-term Long-term Price 8

Harvard Business Review

SEPTEMBER 5, 2016

Yet there’s compelling evidence that bureaucracy creates a significant drag on productivity and organizational resilience and innovation. Operating decisions are almost entirely decentralized. The facility is more than twice as productive as its sister plants in GE Aviation. Juan Díaz-Faes for HBR.

Cost 8

Cost Bureaucracy GDP Management 8

Harvard Business Review

FEBRUARY 6, 2018

Consider its decision to pursue the market for pharmaceutical distribution, or the recent announcement that it will be teaming up with Berkshire Hathaway and JP Morgan Chase to create joint solutions for reducing the health care spending of more than 1 million employees and their families.

Health Care 10

Health Care Retail Operations Insurance 10

Harvard Business Review

SEPTEMBER 20, 2011

economy as a whole, rather than the narrow, specific slices of technology or communication, the first decade of the 21st century did not generate expected growth in jobs, revenues, profits, or stock prices. Apple, the single exception, operates as a startup. When viewed through the lens of the U.S. That's before the Great Recession.

Innovation 12

Innovation Supply Chain Offshoring Policies 12

Harvard Business Review

DECEMBER 19, 2014

As two of his business units were completing their merger, Peter Noll, chief of the Diagnostics division at the Frankfurt-based Scherr Pharmaceuticals, felt it was time to address a nagging issue: The combined entity had no overarching revenue model. There seemed little point. But all patents expire. ” Peter asked pointedly.

Case Study 10

Case Study Price Chemicals Strategy 10

Harvard Business Review

OCTOBER 25, 2018

Increase the number of products that ship from a certain warehouse? Can we identify the optimal price point for our brand in order to maximize growth at a certain level of profitability? This begins with methodically zeroing in on the challenge(s) you’re trying to solve. Are you trying to improve a customer satisfaction rating?

How To 11

How To Pharmaceuticals Process Objective 11

Harvard Business Review

SEPTEMBER 11, 2014

That’s because there are two primary types of uncertainty — demand uncertainty (will customers buy your product?) Finally, industries in the upper-right quadrant — such as software, pharmaceuticals, and medical equipment — face high uncertainty in both demand and technology.

Uncertainty 22

Uncertainty Industry Bottom-up Technology 22

Harvard Business Review

JUNE 20, 2017

Multinational companies operating in Mexico are facing a great deal of uncertainty. For example, a key source of concern for some companies is more-restrictive rules of origin, which would reduce the amount of materials allowed to be used tariff-free for products traded to and from NAFTA member countries. YOY in 2017–2018.

Supply Chain 9

Supply Chain Depreciation Uncertainty Marketing 9

Harvard Business Review

JANUARY 4, 2017

There are similar stories in the electronics industry, pet food, pharmaceuticals, and even national security. However, Section 1502 does not require firms to avoid DRC conflict minerals — it simply requires them to make a good faith effort to disclose the source of the minerals in their products. Two things stood out to us.

Supply Chain 9

Supply Chain Productivity Products Company 9